Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates

Journal of Perinatology

Volumn 29, Issue 12, 2009, Pages 808-813

  Garland, J S ^a   Alex, C P ^a   Uhing, M R ^b   Peterside, I E ^c   Rentz, A ^d   Harris, M C ^c  

^a Wheaton Franciscan Healthcare St Joseph's Hospital   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bloodstream infection; contact dermatitis; healthcare related infection; nosocomial infection

Indexed keywords

CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; DRUG DERIVATIVE; POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; BLOOD; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INDWELLING CATHETER; INFANT; MALE; MICROBIOLOGY; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN ABSORPTION;

ANTI-INFECTIVE AGENTS, LOCAL; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHLORHEXIDINE; DERMATITIS, CONTACT; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PILOT PROJECTS; POVIDONE-IODINE; SKIN ABSORPTION;

EID: 77649241857     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.161     Document Type: Article

References (30)

1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63-71.
2. Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995; 95: 225-230.
3. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR et al. Incidence, presenting features, risk factors, and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17: 593-598.
4. Sohn AG, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover BH et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001; 139: 821-827.
5. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-2365.
6. Smerdely P, Lim A, Boyages SC, Waite K, Wu D, Roberts V et al. Topical iodinecontaining antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancet 1989; 2(8664): 661-664.
7. Parravicini E, Fontana C, Paterlini G, Tagliabue P, Rovelli F, Leung K et al. Iodine, thyroid function, and very low birth weight infants. Pediatrics 1996; 98: 730-734.
8. Gordan CM, Rowitch DH, Mitchell ML, Kohane IS. Topical iodine and neonatal hypothyroidism. Arch Pediatr Adolesc Med 1995; 149: 1336-1339.
9. Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman L. Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid 1997; 7: 395-400.
10. Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996; 24: 1818-1823.
11. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-343.
12. Garland JS, Buck RK, Maloney P, Durkin BM, Toth-Lloyd S, Duffy M et al. A comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995; 14: 510-516.
13. Chaiyakunapruk N, Veenstra DL, Lipsky B, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136: 792-801.
14. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1997; 296: 1305-1309.
15. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-877.
16. Collignon PJ, Soni N, Pearson IY. Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol 1986; 24: 532-535.
17. Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct Gram staining of catheter segments. N Engl J Med 1985; 18: 1142-1147.
18. Garland JS, Alex C, Mueller CP, Cisler-Kahill LA. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatr Infect Dis J 1996; 15: 912-914.
19. Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993; 91: 617-623.
20. Aly R, Mailbach HI. Effect of antimicrobial soap containing chlorhexidine on the microbial flora of skin. Appl Environ Microbiol 1976; 31: 931-935.
21. Shelton DM. A comparison of the effects of two antiseptic agents on staphylococcus epidermis colony forming units at the peritoneal dialysis catheter exit site. Adv Perit Dial 1991; 7: 120-124.
22. Andersen C, Hart J, Vemgal P, Harrison C. Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect 2005; 61: 162-167.
23. Okano M, Nomura M, Hata S, Okada N, Sato K, Kitano Y et al. Anaphylactic symptoms due to chlorhexidine gluconate. Arch Dermatol 1989; 125: 50-52.
24. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 1997; 87: 1242-1244.
25. Garland JS, Alex CP, Sevallius JM, Murphy DM, Good MJ, Volberding AM et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008; 29: 243-249.
26. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107: 1431-1437.
27. Obrien CA, Blummer JL, Speck WT, Carr H. Effect of bathing with a 4% chlorhexidine gluconate solution on neonatal bacterial colonization. J Hosp Infect 1984; 5(Suppl A): 141.
28. Cowen J, Ellis SH, McAinsh J. Absorption of chlorhexidine from intact skin of newborn infants. Arch Dis Child 1979; 54: 379-383.
29. Agget PJ, Copper LV, Ellis SH, McAinsh J. Percutaneous absorption of chlorhexidine in neonatal cord care. Arch Dis Child 1981; 56: 878-891.
30. Case DE, McAinsh J, Rushton A, Winrow MJ. Chlorhexidine: attempts to detect percutaneous absorption in man. Chemotherapy 1976; 3: 367-374.